drugset / Trial / NCT02648958

Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations

NCT02648958 ↗

Completed 68 enrolled Yonsei University
RandomizedParallel-groupDouble-blindPrevention

Summary

Ischemia reperfusion injury causes the release of free oxygen radicals. The selective alpha2-receptor agonist, dexmedetomidine, has an inhibitory effect on inflammatory responses during ischemic injury. The aim of this study is to evaluate the effect of dexmedetomidine on inflammatory responses during ischemia-reperfusion injury in skeletal muscle.

Timeline

Start
2016-01
Primary completion
2017-07-31
Completion
2017-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 mg/kg —

Indications